These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6280088)
21. Enhanced retinal and optic nerve excitability associated with demyelination in mice infected with Semliki Forest virus. Tansey EM; Allen TG; Ikeda H Brain; 1986 Feb; 109 ( Pt 1)():15-30. PubMed ID: 3002541 [TBL] [Abstract][Full Text] [Related]
22. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures. Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371 [TBL] [Abstract][Full Text] [Related]
23. The effect of irradiation on demyelination induced by avirulent Semliki Forest virus. Chew-Lim M; Webb HE; Jagelman S Br J Exp Pathol; 1977 Oct; 58(5):459-64. PubMed ID: 588439 [TBL] [Abstract][Full Text] [Related]
24. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis. Fazakerley JK; Khalili-Shirazi A; Webb HE Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913 [No Abstract] [Full Text] [Related]
25. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice. Smyth JM; Sheahan BJ; Atkins GJ J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955 [TBL] [Abstract][Full Text] [Related]
26. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Sheahan BJ; Gates MC; Caffrey JF; Atkins GJ Acta Neuropathol; 1983; 60(3-4):257-65. PubMed ID: 6310927 [TBL] [Abstract][Full Text] [Related]
27. The identification and role of cells involved in CNS demyelination in mice after Semliki Forest virus infection: an ultrastructural study. Pathak S; Illavia SJ; Webb HE Prog Brain Res; 1983; 59():237-54. PubMed ID: 6320269 [No Abstract] [Full Text] [Related]
28. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus. Parsons LM; Webb HE J Neurol Sci; 1982 Dec; 57(2-3):307-18. PubMed ID: 6298371 [TBL] [Abstract][Full Text] [Related]
29. Changes in fast axonal transport of glycoproteins in optic nerves of mice infected with Semliki Forest virus. Jenkins HG; Ikeda H Brain; 1991 Feb; 114 ( Pt 1A)():309-20. PubMed ID: 1705462 [TBL] [Abstract][Full Text] [Related]
30. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Balluz IM; Glasgow GM; Killen HM; Mabruk MJ; Sheahan BJ; Atkins GJ Neuropathol Appl Neurobiol; 1993 Jun; 19(3):233-9. PubMed ID: 8395026 [TBL] [Abstract][Full Text] [Related]
31. Induction of membrane proliferation in mouse CNS by gold sodium thiomalate with reference to increased virulence of the avirulent Semliki Forest virus. Mehta S; Pathak S; Webb HE Biosci Rep; 1990 Jun; 10(3):271-9. PubMed ID: 2171692 [TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus. Suckling AJ; Jagelman S; Webb HE Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913 [TBL] [Abstract][Full Text] [Related]
33. Demyelination in mice after two or three infections with avirulent Semliki Forest virus. Chew-Lim M; Suckling AJ; Webb HE Vet Pathol; 1977 Jan; 14(1):62-72. PubMed ID: 850996 [TBL] [Abstract][Full Text] [Related]
34. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus. Barrett AD; Dimmock NJ J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526 [TBL] [Abstract][Full Text] [Related]
35. Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures: possible implications for the pathogenesis of multiple sclerosis. Atkins GJ; Sheahan BJ; Mooney DA Neuropathol Appl Neurobiol; 1990 Feb; 16(1):57-68. PubMed ID: 2157171 [TBL] [Abstract][Full Text] [Related]
36. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles. Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976 [TBL] [Abstract][Full Text] [Related]
37. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202 [TBL] [Abstract][Full Text] [Related]
38. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice. Crouch CF; Mackenzie A; Dimmock NJ J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798 [TBL] [Abstract][Full Text] [Related]
39. Optic nerve demyelination induced by human serum: patients with multiple sclerosis or optic neuritis and normal subjects. Sergott RC; Brown MJ; Polenta RM; Lisak RP; Silberberg DH Neurology; 1985 Oct; 35(10):1438-42. PubMed ID: 4033926 [TBL] [Abstract][Full Text] [Related]
40. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. Mokhtarian F; Swoveland P J Immunol; 1987 May; 138(10):3264-8. PubMed ID: 2437186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]